tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:STX Stock Latest News

Shield Therapeutics Updates Market on Total Voting Rights and Share Capital
Company AnnouncementsShield Therapeutics Updates Market on Total Voting Rights and Share Capital
3d ago
Shield Therapeutics Secures $7.9m China Milestone as ACCRUFeR® Nears NMPA Filing
PremiumCompany Announcements
Shield Therapeutics Secures $7.9m China Milestone as ACCRUFeR® Nears NMPA Filing
3d ago
Shield Therapeutics Hits Q4 Cash Flow Positivity as ACCRUFeR Sales Jump 56% in 2025
PremiumCompany Announcements
Shield Therapeutics Hits Q4 Cash Flow Positivity as ACCRUFeR Sales Jump 56% in 2025
12d ago
Shield Therapeutics Confirms Total Voting Rights and Share Capital Structure
PremiumCompany Announcements
Shield Therapeutics Confirms Total Voting Rights and Share Capital Structure
1M ago
Shield Therapeutics Wins FDA Nod to Extend ACCRUFeR Use to Adolescents
PremiumCompany Announcements
Shield Therapeutics Wins FDA Nod to Extend ACCRUFeR Use to Adolescents
1M ago
Shield Therapeutics Announces Block Listing Application to London Stock Exchange
PremiumCompany AnnouncementsShield Therapeutics Announces Block Listing Application to London Stock Exchange
2M ago
Shield Therapeutics Wins Gold at Titan Branding Awards for ACCRUFeR®
Premium
Company Announcements
Shield Therapeutics Wins Gold at Titan Branding Awards for ACCRUFeR®
2M ago
Shield Therapeutics Strengthens Financial Position with Amended Debt Financing
Premium
Company Announcements
Shield Therapeutics Strengthens Financial Position with Amended Debt Financing
2M ago
Shield Therapeutics Advances ACCRUFeR® Clinical Trials in Japan for PAH
PremiumCompany Announcements
Shield Therapeutics Advances ACCRUFeR® Clinical Trials in Japan for PAH
3M ago
Shield Therapeutics to Present Pediatric PK Results at ASH Conference
PremiumCompany Announcements
Shield Therapeutics to Present Pediatric PK Results at ASH Conference
3M ago
Shield Therapeutics’ ACCRUFeR® Gains Approval in South Korea
PremiumCompany Announcements
Shield Therapeutics’ ACCRUFeR® Gains Approval in South Korea
3M ago
Shield Therapeutics Achieves Record Quarterly Performance with ACCRUFeR®
PremiumCompany Announcements
Shield Therapeutics Achieves Record Quarterly Performance with ACCRUFeR®
3M ago
Shield Therapeutics Grants Share Options to CEO Amidst Strategic Growth
PremiumCompany AnnouncementsShield Therapeutics Grants Share Options to CEO Amidst Strategic Growth
4M ago
Shield Therapeutics Announces Share Capital and Market Position of ACCRUFeR®
Premium
Company Announcements
Shield Therapeutics Announces Share Capital and Market Position of ACCRUFeR®
4M ago
Shield Therapeutics Reports Positive Pediatric Trial Results for Ferric Maltol
Premium
Company Announcements
Shield Therapeutics Reports Positive Pediatric Trial Results for Ferric Maltol
4M ago
Shield Therapeutics Raises £1.5 Million to Boost ACCRUFeR® Growth
PremiumCompany Announcements
Shield Therapeutics Raises £1.5 Million to Boost ACCRUFeR® Growth
5M ago
Shield Therapeutics’ ACCRUFeR® Receives FDA Priority Review for Pediatric Use
PremiumCompany Announcements
Shield Therapeutics’ ACCRUFeR® Receives FDA Priority Review for Pediatric Use
5M ago
Shield Therapeutics Reports Strong H1 2025 Results and Global Expansion
PremiumCompany Announcements
Shield Therapeutics Reports Strong H1 2025 Results and Global Expansion
5M ago
Shield Therapeutics Reports Positive Results for Ferric Maltol in Heart Failure Patients
PremiumCompany Announcements
Shield Therapeutics Reports Positive Results for Ferric Maltol in Heart Failure Patients
5M ago
Shield Therapeutics Reports Strong H1 2025 Results and Global Expansion
PremiumCompany AnnouncementsShield Therapeutics Reports Strong H1 2025 Results and Global Expansion
5M ago
Shield Therapeutics Doubles ACCRUFeR® Revenues in Q2 2025
Premium
Company Announcements
Shield Therapeutics Doubles ACCRUFeR® Revenues in Q2 2025
6M ago
Shield Therapeutics Secures Shareholder Support at 2025 AGM
Premium
Company Announcements
Shield Therapeutics Secures Shareholder Support at 2025 AGM
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >